Literature DB >> 7918108

Dimerization characteristics of the DNA- and steroid-binding domains of the androgen receptor.

T Nemoto1, Y Ohara-Nemoto, S Shimazaki, M Ota.   

Abstract

The DNA-binding domain (DBD) of the androgen, mineralocorticoid, and glucocorticoid receptors and the steroid-binding domain (SBD) of the androgen receptor (AR) were expressed separately as fusion proteins with glutathione-S-transferase (GST) in Escherichia coli. Native polyacrylamide gel electrophoresis and gel exclusion HPLC demonstrated that the GST-ARDBD fusion protein was present as a dimer. On the other hand, the GST-ARSBD fusion protein formed a high-molecular weight oligomer, which seemed to be formed by two separate interactions, i.e. GST-GST and ARSBD-ARSBD between the fusion molecules. These findings strongly suggest that ARSBD has a potent ability to form a homodimer and that ARDBD does not. GST-ARDBD specifically interacted with the glucocorticoid response elements of the mouse mammary tumor virus long terminal repeat (GREMMTV). Cleavage of the fusion protein by thrombin abolished the binding, while the nonspecific DNA-cellulose binding ability was retained. Therefore, the dimeric configuration of GST-ARDBD, even if accomplished through the interaction with the GST moiety, is needed for high-affinity binding to the response element. The binding of GST-ARDBD to GREMMTV was strongly competed by the glucocorticoid response element of rat tyrosine aminotransferase gene, followed by the androgen response element of the rat probasin gene. A palindromic thyroid response element showed no competition. Unexpectedly, no apparent different in the binding affinity to these response elements was observed among the DBDs of androgen, mineralocorticoid and glucocorticoid receptors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7918108     DOI: 10.1016/0960-0760(94)90126-0

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  8 in total

1.  Evidence for DNA-binding domain--ligand-binding domain communications in the androgen receptor.

Authors:  Christine Helsen; Vanessa Dubois; Annelien Verfaillie; Jacques Young; Mieke Trekels; Renée Vancraenenbroeck; Marc De Maeyer; Frank Claessens
Journal:  Mol Cell Biol       Date:  2012-05-29       Impact factor: 4.272

2.  Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone.

Authors:  J S Sack; K F Kish; C Wang; R M Attar; S E Kiefer; Y An; G Y Wu; J E Scheffler; M E Salvati; S R Krystek; R Weinmann; H M Einspahr
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

3.  Proteomic analyses to identify novel therapeutic targets for the treatment of advanced prostate cancer.

Authors:  Barbara Comuzzi; Marianne D Sadar
Journal:  Cellscience       Date:  2006-07-27

Review 4.  Cell-based assays for screening androgen receptor ligands.

Authors:  Carmela Campana; Vincenzo Pezzi; William E Rainey
Journal:  Semin Reprod Med       Date:  2015-06-02       Impact factor: 1.303

5.  Oligomeric forms of the 90-kDa heat shock protein.

Authors:  T Nemoto; N Sato
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

6.  Diverged binding specificity of Rim101p, the Candida albicans ortholog of PacC.

Authors:  Ana M Ramón; William A Fonzi
Journal:  Eukaryot Cell       Date:  2003-08

7.  Evolutionary history and functional characterization of androgen receptor genes in jawed vertebrates.

Authors:  Yukiko Ogino; Hironori Katoh; Shigehiro Kuraku; Gen Yamada
Journal:  Endocrinology       Date:  2009-10-09       Impact factor: 4.736

8.  Ligand induced dissociation of the AR homodimer precedes AR monomer translocation to the nucleus.

Authors:  Ryota Shizu; Kosuke Yokobori; Lalith Perera; Lee Pedersen; Masahiko Negishi
Journal:  Sci Rep       Date:  2019-11-13       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.